Ysios Capital Overview
- Investor Type
- Venture Capital
- Status
- Active
- Professionals
- 9
- Investments
- 53
- Portfolio
- 22
- Exits
- 11
Ysios Capital General Information
Description
Founded in 2008, Ysios Capital is a venture capital investment firm that provides private equity financing to early and mid-stage human healthcare and life science companies. The firm is based in San Sebastián, Spain.
Contact Information
Website
Year Founded
2008
Investor Status
Actively Seeking New Investments
Trade Association
Principles for Responsible Investment (PRI)
Primary Investor Type
Venture Capital
Primary Office
- Avenida de la Libertad
- 25 4th floor
- 20004 San Sebastián
- Spain
+34 943 00 00 00
Ysios Capital Investments (53)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Corwave | 06-Jan-2021 | Later Stage VC | 000.00 | Surgical Devices | Pre-Clinical Trials | 00ú0 0000í0-0000 00.0 |
| 0000000000000 | 20-Oct-2020 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | 00000 000000 |
| 0000000 | 25-Sep-2020 | 00000 00000 | 0000 | Drug Discovery | Clinical Trials - General | 00000 000000 |
| 0000 000000000000 | 17-Sep-2020 | 00000 00000 | 0000 | Drug Discovery | Generating Revenue | 00ë0 0000-000000 00.0 |
| 0000000 | 15-Aug-2020 | 00000 00000 | 000.00 | Drug Discovery | Generating Revenue | 00000 000000 |
| 00000 000000000000 | 07-Aug-2020 | 00000 00000 | 0000 | Biotechnology | Generating Revenue | 00000 000000 |
| 00000 | 03-Jul-2020 | 00000 00000 | 0000 | Drug Discovery | Startup | 0000000 0000000 |
| 000000 000 | 22-Jun-2020 | 00000 00000 | 00.000 | Biotechnology | Generating Revenue | |
| Ona Therapeutics | 16-Jun-2020 | Early Stage VC | 000.00 | Drug Discovery | Generating Revenue | 00ë0 0000-000000 00.0 |
| INBRAIN Neuroelectronics | 11-Jun-2020 | Early Stage VC | 00.000 | Diagnostic Equipment | Clinical Trials - Phase 1 |
Ysios Capital Exits (11)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Galecto | 29-Oct-2020 | IPO | 0000 |
| 00000000000 | 01-Sep-2018 | 000 00 00000000 | |
| 0000000 | 31-Jul-2018 | 000000000000000000 | 00000 |
| 0000-00 | 19-Apr-2018 | 000000000000000000 | 00000 |
| 0000000 0000000000 | 16-Mar-2018 | 000000000000000000 | 00000 |
| 0000 0000000000000 | 20-Jul-2017 | 000 | 0000 |
| 000000000 | 19-Aug-2013 | 000000000000000000 | 00000 |
| 00000000 | 05-May-2011 | 000000000000000000 | 000.00 |
| BioVex Group | 04-Mar-2011 | Merger/Acquisition | 00000 |
| Sabirmedical | 07-Jan-2011 | Early Stage VC | 00.000 |
Ysios Capital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
This information is available in the PitchBook Platform. To explore Ysios Capital‘s full profile, request access.
Request a free trialYsios Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialYsios Capital Team (19)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Cristina Garmendia Mendizábal Ph.D | General Partner & Co-Founding Partner | Barcelona, Spain | |||
| Julia Salaverría | Co-Founder & General Partner | 0 | 0 | Barcelona, Spain | |
| Joël Jean-Mairet Ph.D | General Partner & Co-Founder | 00 | 0 | 0 | Barcelona, Spain |
| Karen Wagner | General Partner | 00 | 0 | 0 | Barcelona, Spain |
| Claudia D'Augusta Ph.D | Venture Partner | 0 | Barcelona, Spain |
Ysios Capital Co-Investors (87)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Caixa Capital Risc | 6 | 0 |
|
|
|
| Asabys Partners | 0 | 0 |
|
|
|
| Kurma Partners | 0 | 0 |
|
|
|
| Life Sciences Partners | 0 | 0 |
|
|
|
| Idinvest Partners | 0 | 0 |
|
|